Drug Type Small molecule drug |
Synonyms |
Target |
Action modulators |
Mechanism PDGFR modulators(Platelet-derived growth factor receptor modulators), VEGFR2 modulators(Vascular endothelial growth factor receptor 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Arterial Hypertension | Preclinical | South Korea | 06 Sep 2024 |